International Journal of Cancer Management

Published by: Kowsar
Crossmark

Evaluation of Tumor Resectability Rate and Pathologic Response to Preoperative Concurrent Chemoradiotherapy in Locally Advanced Proximal Gastric and Esophagogastric Junction Adenocarcinomas: A Clinical Trial

Seyed Amir Aledavood 1 , Soodabe Shahid Sales 1 , Kazem Anvari 1 , Mohammad Naser Forghani 1 , Bahram Memar 2 and Ali Emadi Torghabeh 1 , *
Authors Information
1 Cancer Research Center, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, IR Iran
2 Departmen of Pathology, Imam Reza Hospital, Mashhad University of Medical Sciences, Mashhad, IR Iran
Article information
  • International Journal of Cancer Management: May 2017, 10 (5); e7473
  • Published Online: May 30, 2017
  • Article Type: Research Article
  • Received: June 7, 2016
  • Revised: July 23, 2016
  • Accepted: April 29, 2017
  • DOI: 10.5812/ijcm.7473

How to Cite: Aledavood S A, Shahid Sales S, Anvari K, Forghani M N, Memar B, et al. Evaluation of Tumor Resectability Rate and Pathologic Response to Preoperative Concurrent Chemoradiotherapy in Locally Advanced Proximal Gastric and Esophagogastric Junction Adenocarcinomas: A Clinical Trial, Int J Cancer Manag. 2017 ; 10(5):e7473. doi: 10.5812/ijcm.7473.

Abstract
Copyright © 2017, International Journal of Cancer Management. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Methods
3. Results
4. Discussion
Acknowledgements
Footnotes
References
  • 1. Devita VT, Lawrence TS , Rosenberg SA. Cancer: Principle & Practice of Oncology. 2011;
  • 2. Gunderson LL, Sosin H. Adenocarcinoma of the stomach: Areas of failure in a re-operation series (second or symptomatic look) clinicopathologic correlation and implications for adjuvant therapy. Int J Radiat Oncol Biol Phys. 1982; 8(1) : 1 -11 [DOI]
  • 3. Wydmanski J, Suwinski R, Poltorak S, Maka B, Miszczyk L, Wolny E, et al. The tolerance and efficacy of preoperative chemoradiotherapy followed by gastrectomy in operable gastric cancer, a phase II study. Radiother Oncol. 2007; 82(2) : 132 -6 [DOI][PubMed]
  • 4. Siewert JR, Stein HJ. Classification of adenocarcinoma of the oesophagogastric junction. Br J Surg. 1998; 85(11) : 1457 -9 [DOI][PubMed]
  • 5. Ajani JA, Mansfield PF, Janjan N, Morris J, Pisters PW, Lynch PM, et al. Multi-institutional trial of preoperative chemoradiotherapy in patients with potentially resectable gastric carcinoma. J Clin Oncol. 2004; 22(14) : 2774 -80 [DOI][PubMed]
  • 6. Stahl M, Walz MK, Stuschke M, Lehmann N, Meyer HJ, Riera-Knorrenschild J, et al. Phase III comparison of preoperative chemotherapy compared with chemoradiotherapy in patients with locally advanced adenocarcinoma of the esophagogastric junction. J Clin Oncol. 2009; 27(6) : 851 -6 [DOI][PubMed]
  • 7. Ajani JA, Mansfield PF, Crane CH, Wu TT, Lunagomez S, Lynch PM, et al. Paclitaxel-based chemoradiotherapy in localized gastric carcinoma: degree of pathologic response and not clinical parameters dictated patient outcome. J Clin Oncol. 2005; 23(6) : 1237 -44 [DOI][PubMed]
  • 8. van Hagen P, Hulshof MC, van Lanschot JJ, Steyerberg EW, van Berge Henegouwen MI, Wijnhoven BP, et al. Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med. 2012; 366(22) : 2074 -84 [DOI][PubMed]
  • 9. Ajani JA, Winter K, Okawara GS, Donohue JH, Pisters PW, Crane CH, et al. Phase II trial of preoperative chemoradiation in patients with localized gastric adenocarcinoma (RTOG 9904): quality of combined modality therapy and pathologic response. J Clin Oncol. 2006; 24(24) : 3953 -8 [DOI][PubMed]
  • 10. Pepek JM, Chino JP, Willett CG, Palta M, Blazer Iii DG, Tyler DS, et al. Preoperative chemoradiotherapy for locally advanced gastric cancer. Radiat Oncol. 2013; 8 : 6 [DOI][PubMed]
  • 11. Trip AK, Poppema BJ, van Berge Henegouwen MI, Jansen EPM, Siemerink E, Richel DJ, et al. Preoperative chemoradiotherapy (CRT) in gastric cancer. J Clin Oncol. 2013; 31(4)
  • 12. Lowy AM, Feig BW, Janjan N, Rich TA, Pisters PW, Ajani JA, et al. A pilot study of preoperative chemoradiotherapy for resectable gastric cancer. Ann Surg Oncol. 2001; 8(6) : 519 -24 [PubMed]
  • 13. Matsuda S, Takahashi T, Fukada J, Fukuda K, Kawakubo H, Saikawa Y, et al. Phase I study of neoadjuvant chemoradiotherapy with S-1 plus biweekly cisplatin for advanced gastric cancer patients with lymph node metastasis: -KOGC04. Radiat Oncol. 2014; 9 : 9 [DOI][PubMed]
  • 14. Orditura M, Galizia G, Di Martino N, Ancona E, Castoro C, Pacelli R, et al. Effect of preoperative chemoradiotherapy on outcome of patients with locally advanced esophagogastric junction adenocarcinoma-a pilot study. Curr Oncol. 2014; 21(3) : 125 -33 [DOI][PubMed]
  • 15. Valenti V, Hernandez-Lizoain JL, Martinez Regueira F, Gil A, Marti P, Zozaya G, et al. [Analysis of postoperative morbidity in patients with gastric adenocarcinoma treated using a protocol of preoperative chemoradiotherapy and surgery]. Cir Esp. 2009; 86(6) : 351 -7 [DOI][PubMed]
  • 16. Roth AD, Allal AS, Brundler MA, de Peyer R, Mermillod B, Morel P, et al. Neoadjuvant radiochemotherapy for locally advanced gastric cancer: a phase I-II study. Ann Oncol. 2003; 14(1) : 110 -5 [PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments